Advani, Aman, and Saad Ahmed Mughal. 2025. “Luspatercept (REBLOZYL): A Game-Changer in Reducing Transfusion Burden for β-Thalassemia Patients”. Innovative Research in Applied, Biological and Chemical Sciences 3 (1). https://doi.org/10.62497/irabcs.150.